FOR IMMEDIATE RELEASE FEBRUARY 16, 2012
VANCOUVER, CANADA—QLT Inc. (NASDAQ: QLTI; TSX: QLT) today announced that it will release financial results for the fourth quarter ended December 31, 2011 and full year 2011 on Thursday, February 23, 2012.
Company management will host an investor conference call to discuss 2011 results and review recent accomplishments on Thursday, February 23, 2012 at 8:30 a.m. ET (5:30 a.m. PT). The call will be broadcast live via the Internet at www.qltinc.com. To participate on the call, please dial 1-800-319-4610 (North America) or 604-638-5340 (International) before 8:30 a.m. ET. A replay of the call will be available via the Internet and also via telephone at 1-800-319-6413 (North America) or 604-638-9010 (International), access code 7157, followed by the “#” sign.
About QLT
QLT is an ocular-focused company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide.
We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases, developing our proprietary punctal plug delivery system, as well as U.S. marketing of the commercial product Visudyne® (which we co-developed with Novartis) for the treatment of wet age-related macular degeneration.
QLT’s head office is based in Vancouver, Canada and the Company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT). For more information about the Company’s products and developments, please visit our web site at www.qltinc.com.
QLT Inc. Media Contact:
Karen Peterson
Corporate Communications Specialist
Telephone: 604-707-7000 or 1-877-764-3131
[email protected]
QLT Inc. Investor Relations Contact:
David Climie
VP, Investor Relations
Telephone: 604-707-7573
[email protected]
Visudyne® is a registered trademark of Novartis AG.
|
